AstraZeneca Collaborates with ProteinQure to Design Novel Peptide Therapeutics

 AstraZeneca Collaborates with ProteinQure to Design Novel Peptide Therapeutics

AstraZeneca Collaborates with ProteinQure to Design Novel Peptide Therapeutics

Shots:

  • The collaboration will deploy ProteinQure’s computational methods and structure-based drug design along with AstraZeneca’s expertise in biologics to conduct experimental validation
  • The focus of the collaboration is to create therapeutic libraries for accelerating the research and development of peptide therapeutics
  • Integrating ProteinQure’s computational tools with AstraZeneca’s ability to refine and validate millions of therapeutic candidates in high throughput leading towards the rapid determination of therapeutic leads outside the scope of conventional synthetic antibody libraries

Click here to read full press release/ article | Ref: PRNewswire | Image: Pharmashots

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post